Poster Session 1: Immune Reconstitution
Poster Abstracts
Longhorn Hall E (Exhibit Level 1) (Gaylord Texan)
Baseline Thymopoietic Function and Post-Transplant Immune Recovery after Adult Cord Blood Transplantation
Cara L. Benjamin, PhD, Sylvester Cancer Center - University of Miami;
Rima Saliba, PhD, University of Texas, MD Anderson Cancer Center;
Elizabeth J. Shpall, MD, UT MD Anderson Cancer Center;
Marcos J. G. de Lima, MD, University Hospital Case Medical Center;
Lisa St. John, PhD, MD Anderson Cancer Center;
Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC;
Richard E. Champlin, MD, UT MD Anderson Cancer Center;
Krishna Komanduri, MD, University of Miami
Phenotypic and Functional Characteristics of NK Cells Associated with Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Ryotaro Nakamura, MD, City of Hope;
Anne Franck, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA;
Ghislaine Gallez-hawkins, Beckman Research Institute, City of Hope National Medical Center;
Laetitia Jeannet, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA;
Xiuli Li, City of Hope;
Stephen J. Forman, MD, City of Hope National Medical Center;
John A. Zaia, MD, Beckman Research Institute of City of Hope
Maintenance of Naïve T Cells and a Diverse TCR Repertoire Are Critical for Reconstitution of EBV-Specific Immunity after Double Cord Blood Transplantation
Ioannis Politikos, MD, Beth Israel Deaconess Medical Center, Harvard Medical School;
Haesook T Kim, PhD, Dana-Farber Cancer Institute;
Sarah Nikiforow, MD PhD, Dana-Farber Cancer Institute;
Anoma Nellore, MD, Beth Israel Deaconess Medical Center, Harvard Medical School;
Lequn Li, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School;
Sean M McDonough, MS, Dana-Farber Cancer Institute;
Robert J. Soiffer, MD, Dana-Farber Cancer Institute;
Joseph H Antin, MD, Dana-Farber Cancer Institute;
Karen K. Ballen, MD, Massachusetts General Hospital;
Corey S. Cutler, MD, Dana-Farber Cancer Institute;
Jerome Ritz, MD, Dana-Farber Cancer Institute;
Vassiliki A. Boussiotis, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School
